Biomarkers in the diagnosis of Alzheimer's disease: are we ready? (Q31050728)

28 June 2017

1 reference

title

Biomarkers in the diagnosis of Alzheimer's disease: are we ready? (English)

1 reference

28 June 2017

0 references

0 references

2

Harald Hampel

1 reference

28 June 2017

Trey Sunderland

1

1 reference

28 June 2017

Masatoshi Takeda

series ordinal

3

1 reference

28 June 2017

Karen T Putnam

series ordinal

4

1 reference

28 June 2017

Robert M Cohen

series ordinal

5

1 reference

28 June 2017

1 September 2006

1 reference

Journal of Geriatric Psychiatry and Neurology

28 June 2017

1 reference

28 June 2017

19

1 reference

28 June 2017

172-179

1 reference

28 June 2017

3

1 reference

Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care

28 June 2017

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

The use of biomarkers in the elderly: current and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Research evaluation and prospective diagnosis of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

A potential noninvasive neurobiological test for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

CSF tau and Abeta42: logical biomarkers for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

CSF markers for incipient Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

CSF phosphorylated tau--does it constitute an accurate biological test for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Fine-needle, negative-pressure lumbar puncture: a safe technique for collecting CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Safety and acceptability of the research lumbar puncture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

The Alzheimer's disease neuroimaging initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Virtual colonoscopy in the detection of colonic polyps and neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by 'stages': a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Imaging cerebral atrophy: normal ageing to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Longitudinal stability of CSF tau levels in Alzheimer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Biological markers for the clinical diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Advances in the early detection of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

CSF phosphorylated tau protein and mild cognitive impairment: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

Medial temporal lobe function and structure in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988706291088

21 January 2018

Identifiers

DOI

10.1177/0891988706291088

1 reference

28 June 2017

1 reference